X-Cor Therapeutics
Founded Year
2017Stage
Seed VC | AliveTotal Raised
$2.8MLast Raised
$2.6M | 1 yr agoLatest X-Cor Therapeutics News
Nov 12, 2020
X-COR Therapeutics , an Allston, MA-based developer of a novel extracorporeal carbon dioxide removal device, closed a $2.6M seed financing. Alira Health’s investment arm, Alira Health Ventures, led the financing with syndication from Good Growth Capital, PiSA Biopharm, Flybridge Partners’ Graduate Syndicate, and other notable angel investors. The company intends to use the funds to continue developing its device toward clinical trials. Led by Jayon Wang, CEO, X-COR is a medical device company creating a carbon dioxide removal device that uses ultra-low-blood flows for the treatment for acute respiratory failure. Its novel technology is a patent-pending medical device and accompanying control algorithm that enables physicians to directly remove excess carbon dioxide from lung failure patients. FinSMEs
Expert Collections containing X-Cor Therapeutics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
X-Cor Therapeutics is included in 1 Expert Collection, including Medical Devices.
Medical Devices
7,884 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
